These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 523342)
1. Alteration of brain noradrenaline, dopamine and 5-hydroxytryptamine levels during vanadium poisoning. Witkowska D; Brzeziński J Pol J Pharmacol Pharm; 1979; 31(4):393-8. PubMed ID: 523342 [TBL] [Abstract][Full Text] [Related]
2. Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the rat. Benfield DP; Luscombe DK Arzneimittelforschung; 1983; 33(6):847-50. PubMed ID: 6684438 [TBL] [Abstract][Full Text] [Related]
3. The effect of alpha, alpha1-dipyridyl on noradrenaline, dopamine and 5-hydroxytryptamine levels and on dopamine-beta-hydroxylase activity in brain. Mogilnicka E; Szmigielski A; Niewiadomska A Pol J Pharmacol Pharm; 1975; 27(6):619-24. PubMed ID: 1715 [TBL] [Abstract][Full Text] [Related]
4. Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats. Sheikh N; Ahmad A; Siripurapu KB; Kuchibhotla VK; Singh S; Palit G J Ethnopharmacol; 2007 May; 111(3):671-6. PubMed ID: 17321089 [TBL] [Abstract][Full Text] [Related]
5. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue. Tseng LF; Menon MK; Loh HH J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280 [TBL] [Abstract][Full Text] [Related]
6. Effects of histamine H1- and H2-receptor antagonists on dopamine, noradrenaline and serotonin systems in rat brain. Nowak JZ Pol J Pharmacol Pharm; 1980; 32(4):451-61. PubMed ID: 6114483 [TBL] [Abstract][Full Text] [Related]
7. Influence of supidimide on brain neurotransmitter systems of rats and mice. Hennies HH; Günzler WA; Flohé L Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511 [TBL] [Abstract][Full Text] [Related]
8. Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain. Ardis TC; Cahir M; Elliott JJ; Bell R; Reynolds GP; Cooper SJ J Psychopharmacol; 2009 Jan; 23(1):51-5. PubMed ID: 18562433 [TBL] [Abstract][Full Text] [Related]
9. Central effects of prostaglandins F2alpha and E1. Herman ZS; Kmieciak-Kolada K; Wolny HL; Slomińska-Zurek J; Bonczek A Pol J Pharmacol Pharm; 1976; 28(5):411-21. PubMed ID: 1012972 [TBL] [Abstract][Full Text] [Related]
10. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives. Tessel RE; Rutledge CO J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279 [TBL] [Abstract][Full Text] [Related]
11. Time-course of trimethyltin effects on the monoaminergic systems of the rat brain. Andersson H; Luthman J; Lindqvist E; Olson L Neurotoxicology; 1995; 16(2):201-10. PubMed ID: 7566680 [TBL] [Abstract][Full Text] [Related]
12. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine. Chen NH; Reith ME J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765 [TBL] [Abstract][Full Text] [Related]
13. High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex. Yoshitake T; Yoshitake S; Fujino K; Nohta H; Yamaguchi M; Kehr J J Neurosci Methods; 2004 Dec; 140(1-2):163-8. PubMed ID: 15589346 [TBL] [Abstract][Full Text] [Related]
14. Effect of some quinolizidine derivatives on the release of serotonin, noradrenaline, dopamine and acetylcholine from rat brain synaptosomes. Sparatore A; Marchi M; Maura G; Raiteri M Farmaco; 1989 Dec; 44(12):1205-16. PubMed ID: 2634407 [TBL] [Abstract][Full Text] [Related]
15. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. Kihara T; Ikeda M J Pharmacol Exp Ther; 1995 Jan; 272(1):177-83. PubMed ID: 7815331 [TBL] [Abstract][Full Text] [Related]
16. Effects of chronic diazepam and medazepam treatment on the level of biogenic monoamines in different rat brain areas. Stancheva S; Petkov VV Acta Physiol Pharmacol Bulg; 1988; 14(3):26-31. PubMed ID: 2906206 [TBL] [Abstract][Full Text] [Related]
17. Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment. Ahtee L; Attila LM; Carlson KR J Pharmacol Exp Ther; 1990 Nov; 255(2):803-8. PubMed ID: 2243351 [TBL] [Abstract][Full Text] [Related]
18. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain. Petkov VV; Grahovska T; Petkov VD; Konstantinova E Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335 [TBL] [Abstract][Full Text] [Related]
19. Effects of chronic exposure to cadmium, lead and mercury of brain biogenic amines in the rat. Hrdina PD; Peters DA; Singhal RL Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):483-93. PubMed ID: 996361 [TBL] [Abstract][Full Text] [Related]
20. [Effect of prolonged hypokinesia on the biogenic amine content of rat brain synaptosomes]. Panusheva NN Biull Eksp Biol Med; 1983 Dec; 96(12):12-4. PubMed ID: 6686464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]